21st Oct 2020 20:27
Yourgene Health PLC - molecular diagnostics firm - Announces new collaboration between the recently launched Yourgene Genomic Services and Cytox Ltd for a beta-testing genomic study on their genetic risk test for Alzheimer's disease. Under the YGS offering, Yourgene Health will validate and verify the performance of the Cytox genoSCORE-LAB1 process for both whole blood and saliva samples, to ensure the robust and reproducible detection of genotypes necessary to calculate individual polygenic risk scoring.
Current stock price: 19.24 pence
Year-to-date change: up 47%
By Arvind Bhunjun; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
YGEN.L